Treatment of Parkinson's disease with α-dihydroergocryptine in neurological practice - Results of an observational study;Therapie des morbus Parkinson mit α-dihydroergocryptin in der neurologischen praxis. Ergebnisse einer anwendungsbeobachtung

Aktuelle Neurologie

Volumn 25, Issue 5, 1998, Pages 198-201

  Jorg J ^a  

^a UNIVERSITY OF WITTEN HERDECKE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DIHYDROERGOCRYPTINE; DOPAMINE RECEPTOR STIMULATING AGENT; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; DISEASE ACTIVITY; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATION; PARKINSON DISEASE; TREATMENT OUTCOME;

EID: 0031856904     PISSN: 03024350     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1017690     Document Type: Article

References (10)

1. 1 Ahlskog, J. E., M. D. Muenter: Treatment of Parkinson's disease with pergolide: A double-blind study. Mayo Clin. Proc. 63 (1988) 969-978
2. 2 Battistin, L., P. G. Gardin, F. Ferro-Milone et al.: Dihydroergocryptine and Parkinson's disease: a double-blind multicentre study vs. lisuride. In: Poli-Symposium: Dihydroergocryptine - a new dopamine-agonist. July 12, 1990. Proc. Atti., John Libbey CIC, Rome, Milan, Paris, New York (1991) 31-49
3. 3 Boas, J., J. Worm-Petersen, E. Dupont et al.: The levodopa dosesparing capacity of pergolide compared with that of bromocriptine in an open-label, crossover study. Eur. J. Neurol. 3 (1996) 44-49
4. 4 Bonuccelli, U., P. D'Antonio, C. D'Avino et al.: Dihydroergocryptine in the treatment of Parkinson's disease. J. Neural. Transm. 45 (1995) 239-245
5. 5 Martignoni, E., C. Pacchetti, L Sibilla et al.: Dihydroergocryptine in the treatment of Parkinson's disease: A six months' doubleblind clinical trial. Clin. Neuropharmacol. 14 (1991) 78-83
6. 6 Mizuno, Y, T. Kondo, H. Narabayashi: Pergolide in the treatment of Parkinson's disease. Neurology 45, Suppl. 3 (1995) S 13 -S 21
7. 7 Olanow, C. W., S. Fahn, M. Muenter et al.: A multicenter double-blind placebo-controlled trial of pergolide as an adjunct to Sinemet® in Parkinson's disease. Movement Disord. 9 (1994) 40-47
8. 8 Scarzella, L., R. Cantello, M. Delsedime et al.: Clinical trial on the therapeutic activity of dihydroergocryptine in parkinsonism: Preliminary results. Curr. Ther Res. 38 (1985) 432-440
9. 9 Stocchi, F., S. Ruggieri, G. Brughitta et al.: Comparative clinical study on the effectiveness of two ergot derivatives, bromocriptine and dihydroergocryptine in the treatment of Parkinson's disease. Biol. Med. 7 (1985) 191-200
10. 10 Dihydroergocryptine Parkinson's disease Italian Study Group: Controlled, double-blind study of α-dihydroergocryptine in the treatment of de novo parkinsonian patients: six-month results. Abstract, 12th International Symposium on Parkinson's Disease, London 1997. Movement Disord. 12, Suppl. 1 (1997) 81